Historial de carrera de Feng Tian
Antiguos cargos conocidos de Feng Tian.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Director/Miembro de la Junta | 01/07/2018 | 01/11/2020 |
| Director Ejecutivo | 01/07/2018 | 15/08/2022 | |
| Presidente | 01/11/2020 | 15/08/2022 | |
| Director Técnico/Científico/I+D | 01/01/2015 | 01/07/2018 | |
| Presidente | 01/07/2018 | 15/08/2022 | |
| LuxVitae Therapeutics, Inc. | Fundador | - | - |
| AMBRX INC | Director Ejecutivo | - | - |
| Presidente | - | - | |
| Director Técnico/Científico/I+D | 17/06/2015 | - | |
| Presidente | - | - |
Formación de Feng Tian.
| University of Florida | Doctorate Degree |
| Peking University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 4 |
| Islas Caimán | 2 |
| China | 2 |
Operativa
| Chief Executive Officer | 2 |
| Chairman | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Ambrx, Inc.
 Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Ambrx Biopharma Cayman, Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA. | Health Technology |
| LuxVitae Therapeutics, Inc. |
- Bolsa de valores
- Insiders
- Feng Tian
- Experiencia